CVS HEALTH Corp · Drug Stores and Proprietary Stores

CVS

Low riskNext report: In 1 days (est.)

View price ↗

The short version

A profitable company with steady sales. Institutions are adding.

Going well

Profitable
Brings in more cash than it spends
Buying back shares: share count down 3.9% in 3 years

Money moves

No insider buying or selling in the last 30 days
Institutions added 3.4% to their holdings in the quarter ending June 2026 (1065 bought, 830 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$92.53-1.0% that day

Company value: $118.3B; Share price times all shares
Price vs profit (P/E): 24.4x; You pay about $24 for each $1 of yearly profit
Price vs sales: 0.29x; Company value is 0.29 times a year of sales
Dividend yield: 2.9%; Yearly dividend as a share of today's price
Cash vs value: 10%; Cash as a share of company value
Debt vs value: 51%; Debt as a share of company value

From CVS's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$106.1B+7.3% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $415.1B, up 7.4% from the 12 months before. Over 5 years, sales grew about 8.4% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of CVS. Starting points are the company's recent numbers.

Sales growth+7% a yearRecently: +7.4% a yearProfit margin1%Last 12 months: 1.2%P/E at the end24xToday: 24.4x. Many steady companies trade at 12x to 25xShare count change-1% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$582.2B

Profit in 5 years$5.8B

Price these guesses point to$114.88+24% vs $92.53 todayAbout +4.4% a year, before dividends

What today's price needs: with a 1% margin and a 24x P/E, sales would have to grow about 2.5% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

2/6Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.2.3%
MissDebt under half of equityNot relying on borrowed money.0.80x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.0.4%
MissProfitable every yearSteady profits, not one good year.9 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$7.8B
PassShare count not growingNot diluting owners. Falling means buybacks.-3.9% in 3 years

Revenue: $402.1B; +7.8% vs prior year
5-year growth: +8.4%/yr; revenue, per year
Total debt: $60.5B; 0.80x equity
Current ratio: 0.84x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.